$PLBY

Honey Birdette’s comp sales jump 15%

Playboy Inc. said its Honey Birdette brand delivered 18.2% year-over-year sales growth in Q2 2026, with gross margin at 65.1%. Comparable store sales rose 15%. Playboy reported group sales up 11% to US$31.2m, DTC revenue at US$19.5m, and net income of US$0.2m versus a US$7.7m loss a year earlier.

Original reporting
Published Aug 11, 2026, 4:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 4:18 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Honey Birdette’s comp sales jump 15% — source image
Decision brief

The 30-second read

$PLBYBullishMed
01

Why it matters

Honey Birdette’s 15% comp sales lift and 65.1% gross margin in Q2 coincide with Playboy’s 11% group revenue growth and a swing to net positive income, indicating improved operating leverage.

02

Market read

Traders can update PLBY’s profitability and DTC growth assumptions based on the disclosed Q2 comp sales, gross margin, and net income inflection tied to Honey Birdette.

03

What to watch

The article does not quantify store expansion, inventory levels, or promotional intensity, which are key to assessing whether the margin gains are sustainable.

Relevance 7/10Novelty 6/10Timing: Q2 results update reported pre-market today

Background

Honey Birdette is a lingerie brand owned via licensing by Playboy, and the article frames its Q2 performance as a driver of Playboy’s group results.

Company-level read

Ticker impact

$PLBYBullishMedium confidence
Context

Playboy reported Honey Birdette drove 18.2% YoY sales growth in Q2 and lifted group revenue 11% to $31.2M.

Expected impact

Near-term upside bias for PLBY on improved profitability signals, with follow-through dependent on sustaining gross margin and comp growth.

Evidence & confidence

The article provides specific Q2 growth and margin figures plus a net income inflection, which are actionable for earnings-model updates even without a full guidance update.

Market effects

Supports the consumer discretionary apparel/luxury lingerie read-through that full-price mix and discount discipline can expand gross margins.

Highlights continued traction across Australia, US, and UK channels, reducing regional concentration risk.

Reinforces that licensing and DTC brand engines can drive profitability even for smaller-cap consumer names.

Counterpoint

Margin strength could be partly mix-driven and may normalize if discounting returns, limiting durability of the comp and gross margin trend.

Key entities

  • Playboy Inc.

    US owner of Honey Birdette; reported Q2 group revenue up 11% and net positive income, citing Honey Birdette growth and margin expansion.

  • Honey Birdette

    Lingerie brand whose Q2 comp sales and gross margin performance are presented as the main driver of Playboy’s DTC revenue growth.

Related articles

$PLBYMed

Playboy, Inc. (PLBY): Results of Operations and Financial Condition

Playboy, Inc. (PLBY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q226earningsreleaseex991.htm EX-99.1 Document Exhibit 99.1 Playboy Reports Second Quarter 2026 Financial Results Second Quarter Revenue of $31.2 Million, an Increase of 11%; Net Income of $0.2 Million, an Improvement of $7.9 Million; and Adjusted EBITDA of $7.0 Million,

$PLBYMedAI 8/10

Playboy to Repurchase 16.6 Million Shares at 28% Discount to Market Value

Playboy, Inc. (NASDAQ: PLBY) said it agreed June 18, 2026 to repurchase about 16.6 million shares—Fortress Investment Group affiliates’ entire stake—at $1.05 per share for about $17.4 million. The deal is nearly 15% of outstanding shares and includes $2.0 million at closing plus three installments through Dec. 31, 2026. Rizvi Traverse and Byborg affiliates backstop remaining payments.

$BKKTMed

Bakkt Inc (BKKT) (Q2 2026) Earnings Call Highlights: Strong GAAP Net Income

Bakkt’s CEO Akshay Naheta said the company expects adjusted EBITDA break-even in Q4 2026, without a specific date, citing execution and client activations. Management discussed take rates, cross-border margins, and reaffirmed a 2026 TTV target of about $2.5 billion. The firm outlined post-DTR acquisition progress and Bakkt Agent MAU target of ~25,000 by year-end 2026.

$RKLBMedAI 8/10

Rocket Lab revenue hits a record US$234 million while the losses keep coming

Rocket Lab reported record Q2 revenue of US$234.1 million, up 62% year over year, with gross profit rising to US$84.6 million and gross margin to 36.1%. It posted a net loss of US$49.3 million. Backlog rose to US$2.36 billion. Guidance for Sept quarter: revenue US$250-265 million; adjusted loss US$17-23 million; gross margin 29-31%. Shares fell after results.

$HALOHighAI 9/10

Halozyme Therapeutics (HALO) Shares Skyrocket, What You Need To Know

Halozyme Therapeutics (NASDAQ:HALO) shares rose about 18% after the company reported Q2 adjusted EPS of $2.28 on revenue of $481 million, beating consensus of $1.82 and $404.3 million. Halozyme cited 47.7% YoY revenue growth from ENHANZE royalties and milestones. It raised full-year guidance to $1.87B revenue and $8.83 adjusted EPS midpoint.

$FIVNHighAI 9/10

Five9 (FIVN) Stock Trades Up, Here Is Why

Five9 (NASDAQ:FIVN) shares rose about 18% after the company reported Q2 results above Wall Street expectations. Adjusted EPS was $0.70 on revenue of $312.4 million, with revenue up 10.3% year over year. Five9 raised full-year revenue guidance to $1.27 billion at the midpoint and forecast next-quarter sales above consensus.